Paper Details
- Home
- Paper Details
[Clinical evaluation of S 6472 granule preparation (sustained-release cefaclor) in chronic bronchitis].
Author: HiragaY, OmichiM, SasaokaS
Original Abstract of the Article :
S 6472 granule preparation, a sustained-release cefaclor, was orally administered to 20 acutely exacerbated cases of chronic bronchitis at a daily dosage of 750 mg (titer) in 2 divided doses for a duration of 7-15 days and its clinical usefulness was evaluated. Clinical efficacies were good in 17 ca...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/3241328
データ提供:米国国立医学図書館(NLM)
Clinical Evaluation of a Sustained-Release Cefaclor Granule Preparation for Chronic Bronchitis
This research delves into the world of respiratory medicine, specifically focusing on the effectiveness of a sustained-release cefaclor granule preparation in treating chronic bronchitis. The study employed a clinical trial design, administering the drug to patients experiencing acute exacerbations of chronic bronchitis. The researchers aimed to assess the clinical efficacy of the medication and its impact on the bacterial strains associated with the condition. Their findings revealed a promising rate of efficacy, with a majority of patients exhibiting improvement. Moreover, they observed a reduction in the prevalence of various bacterial strains, indicating the drug's potential for controlling infections. Notably, the study highlights the absence of significant side effects or abnormal laboratory values, suggesting a favorable safety profile.
Cefaclor Granule Preparation: A Potential Treatment for Chronic Bronchitis
The results indicate that this sustained-release cefaclor granule preparation may be a valuable therapeutic option for managing chronic bronchitis. The 85% efficacy rate suggests that this drug could offer significant relief for patients struggling with this condition. However, further research is needed to determine the long-term effects and optimal dosage for different patient populations.
Managing Chronic Bronchitis: A Balancing Act
Chronic bronchitis is a persistent condition, and it is essential to remember that every individual responds differently to treatment. The findings of this study offer hope, but it is crucial to consult a healthcare professional for personalized advice and a tailored treatment plan.
Dr. Camel's Conclusion
Just like a camel navigating a vast desert, managing chronic bronchitis requires a multi-pronged approach. While this study provides valuable insights, it underscores the need for continued research and a personalized approach to treatment. Remember, dear readers, good health is like a precious oasis in the desert – cherish it and seek proper guidance to maintain its beauty.
Date :
- Date Completed 1989-05-18
- Date Revised 2016-11-16
Related Literature
Japanese
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.